Yanwei Chen
Impact in
- Ophthalmology top 5%
- Retinal Diseases and Treatments
-
- MicroRNA in disease regulation
Papers in
-
- RNA Interference and Gene Delivery 2
- Oncology 8
- CAR-T cell therapy research 5
- Co-authors
- Xi Shen (8 shared papers)Jianfang Li (1 shared paper)Yan Yan (1 shared paper)Yongheng Shu (7 shared papers)Ping Cheng (7 shared papers)Bin Zhang (5 shared papers)Jinhu Ma (6 shared papers)Chao Su (3 shared papers)
In The Last Decade
Yanwei Chen
36 papers receiving 490 citations
Peers
Comparison fields: 5 of 65
- Ophthalmology 93
- Cancer Research 78
- Infectious Diseases 60
- Immunology 64
- Oncology 63
Countries citing papers authored by Yanwei Chen
This map shows the geographic impact of Yanwei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanwei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanwei Chen more than expected).
Fields of papers citing papers by Yanwei Chen
This network shows the impact of papers produced by Yanwei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanwei Chen. The network helps show where Yanwei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Yanwei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 157 | |
| 2 | 2016 | 77 | |
| 3 | 2019 | 39 | |
| 4 | 2021 | 23 | |
| 5 | 2021 | 21 | |
| 6 | 2019 | 18 | |
| 7 | 2023 | 15 | |
| 8 | 2020 | 13 | |
| 9 | 2022 | 11 | |
| 10 | 2022 | 10 | |
| 11 | 2020 | 9 | |
| 12 | 2021 | 9 | |
| 13 | 2021 | 8 | |
| 14 | 2021 | 7 | |
| 15 | 2021 | 7 | |
| 16 | 2024 | 6 | |
| 17 | 2021 | 6 | |
| 18 | 2016 | 6 | |
| 19 | 2022 | 6 | |
| 20 | 2020 | 6 |
About Yanwei Chen
Yanwei Chen is a scholar working on Molecular Biology, Oncology, Ophthalmology, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism, having authored 40 papers that have together received 497 indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (6 papers), CAR-T cell therapy research (5 papers), Retinal Diseases and Treatments (5 papers), Virus-based gene therapy research (5 papers), Viral gastroenteritis research and epidemiology (4 papers), Retinal and Macular Surgery (3 papers), Ferroptosis and cancer prognosis (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Ophthalmology (93 citations), Cancer Research (78 citations), Infectious Diseases (60 citations), Immunology (64 citations) and Oncology (63 citations). Yanwei Chen has collaborated with scholars based in China, Hong Kong and Japan. Frequent co-authors include Xi Shen, Jianfang Li, Yan Yan, Yongheng Shu, Ping Cheng, Bin Zhang, Jinhu Ma, Chao Su, Anliang Huang and Gang Shi. Their work appears in journals such as BMC Ophthalmology, Frontiers in Endocrinology, Journal of Computational Biology, Journal of Ocular Pharmacology and Therapeutics and Cell Cycle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.